ArticleFrontiers in pharmacology2026

Placebo-associated changes in MRI-PDFF and metabolic parameters in MASLD patients from phase Ib/IIa clinical trials: implications for early-phase trial design and translational endpoint interpretation.

Mengdi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.